Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
Bogdana SchmidtRenu S EapenJanet E CowanJeanette M BroeringKirsten L GreenePeter R CarrollMatthew R CooperbergPublished in: Prostate cancer and prostatic diseases (2018)
The use of ADT in conjunction with primary EBRT has increased in frequency and duration since 1990. Men receiving ADT have higher risk characteristics than those receiving EBRT alone. There is substantial variability in use of ADT in clinical practice.
Keyphrases